University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > Drug Dosing Toolkit > Edurant

Edurant (rilpivirine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor

Nucleoside reverse transcriptase inhibitors were the first type of drug available to treat HIV. They are also known as NRTIs, nucleoside analogues, or "nukes."

When the HIV virus enters a healthy cell, it attempts to make copies of itself. It does this by using an enzyme called reverse transcriptase. NRTIs block that enzyme, so HIV cannot make new copies of itself.

gray line
transparent gif

Approved adult dosing

25 mg (one 25 mg tablet), once daily with a meal

  • Daily

    photo of edurant pill

    Edurant (25 mg)

Notes on taking this medication

  • Take with a meal (do not take without food)
  • Edurant can interact with other drugs; persons using Edurant with those drugs may need an adjustment to their dose of the other drugs or avoid certain combinations; consult your medical provider

Side effects

  • Rash (usually is mild to moderate. If severe rash develops, contact your medical provider)
  • Nausea
  • Depression, mood changes
  • Edurant has not been studied during pregnancy; tell your medical provider if you become pregnant while taking this drug

See accompanying chart: Tips for Common Side Effects

My doctor's instructions

transparent gif
Contents
transparent gifScroll over drug name to see other names for the drug.
transparent gif
transparent gif
transparent gif